PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Lanosterol 14 Alpha-Demethylase 101 Target Target 11-Beta-Hydroxylase 721 1 0.00 -0.99 0.01 0.68
Angiotensin Converting Enzyme 31,674 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Arrhythmia 29,330 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Dehydration 21,928 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Diarrhea 51,986 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Major Depressive Disorder 12,517 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
APOE 12,771 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Epilepsy 71,172 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Platelet Activating Factor 9,915 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Dyslipidemia 15,225 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
EGF 27,487 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
CD4 112,219 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 1 0.00 -1.00 0.00 0.53
CD1A 2,739 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.63
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
CEA 17,022 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.58
BAFF 1,240 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.65
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
Epidermal Growth Factor Receptor 24,772 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
CD4 112,219 Target Target A1AT 329 1 0.00 -1.00 0.00 0.52
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
ERK1 18,374 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
CD4 112,219 Target Target A1M 59 1 0.00 -0.99 0.02 0.55
Platelet Aggregation 25,460 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Colon Cancer 30,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Lung Cancer 91,416 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Bronchitis 18,336 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Diabetes 332,602 Disease Target AACT 109 1 0.00 -1.00 0.01 0.52
Hormone Replacement Therapy 11,020 Disease Target AACT 109 1 0.00 -1.00 0.01 0.60
CD4 112,219 Target Target AACT 109 1 0.00 -1.00 0.01 0.54
Social Anxiety 3,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.63
Hearing Loss 30,622 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
CEA 17,022 Target Target AACT 109 1 0.00 -1.00 0.01 0.58
Osteoarthritis 36,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Anxiety 113,510 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Prostate Cancer 71,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55